Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease.
Joelynn DaileyLina KozhayaMikail DoganDena HopkinsBlaine LapinKatherine HerbstMichael BrimacombeKristen GrandonicoFatih KarabacakJohn SchreiberBruce Tsan-Liang LiangJuan C SalazarDerya UnutmazJeffrey S HyamsPublished in: Inflammatory bowel diseases (2021)
The lower and less durable SARS-CoV-2 S-RBD IgG response to natural infection in IBD patients receiving biologics puts them at risk of reinfection. The robust response to immunization is likely protective.